Zobrazeno 1 - 10
of 169
pro vyhledávání: '"Harry, Dorchy"'
Autor:
Brink SJ; New England Diabetes and Endocrinology Center (NEDEC), Waltham, MA 02451-1136, USA. stubrink@aol.com
Publikováno v:
Revue medicale de Bruxelles [Rev Med Brux] 2010; Vol. 31 (2 Suppl), pp. S29-36.
Autor:
Harry, Dorchy
Publikováno v:
Revue medicale de Bruxelles. 31
"Monsieur Le Professor Harry Dorchy is retiring". He has had a brilliant 40 year career since receiving his medical degree from the Free University of Brussels in 1969 and his PhD--entitled " Contribution a l'etude du diabète de l'enfant et de l'ado
Publikováno v:
Endocrinology, Diabetes & Metabolism, Vol 5, Iss 1, Pp n/a-n/a (2022)
Abstract Background The aim of the present study was to describe the prevalence and progression of DR diagnosed by fluorescein angiography (FA) in patients with type 1 diabetes (T1D) during a 30‐year follow‐up, and the relationship with glycated
Externí odkaz:
https://doaj.org/article/62b4f464cdc54367baa6ad400a0cdfc6
Autor:
Harry Dorchy
Publikováno v:
Academia Letters.
Autor:
Mark R. Palmert, Soren E. Skovlund, Henk-Jan Aanstoot, Premyslawa K Jarosz-Chobot, Fergus J. Cameron, Mirjana Kocova, Harry Dorchy, Andreas Neu, Giovanni Chiari, Pål R. Njølstad, Henrik B. Mortensen, Peter G.F. Swift, Tatsuhiko Urakami, Timothy Barrett, Lynda K. Fisher, Jean-Jacques Robert, Shlomit Shalitin, Thomas Danne, Eero A. Kaprio, Jan Åman, Carine de Beaufort, Timothy Skinner, Karin Lange, Hilary Hoey, Francesco Chiarelli, Edna Roche, Cintia G Castro-Correia, Luis Castaňo, Eugen Schönle
Publikováno v:
Pediatric Diabetes. 19:559-565
OBJECTIVE The reason for center differences in metabolic control of childhood diabetes is still unknown. We sought to determine to what extent the targets, expectations, and goals that diabetes care professionals have for their patients is a determin
Publikováno v:
Pediatric Diabetes.
BACKGROUND Diabetic ketoacidosis (DKA) is the leading cause of morbidity and mortality in children with type 1 diabetes (T1D). Little is known about the association between genetic and immunological markers and the risk for DKA at onset of T1D. The a
Publikováno v:
Diabetes & Metabolism. 42:207-210
Autor:
Harry Dorchy
Publikováno v:
Current Research in Diabetes & Obesity Journal. 5
Autor:
Athanasia Stoupa, Harry Dorchy
Publikováno v:
Pediatric Diabetes. 17:342-350
Aim: The aim of this study was to compare genetic (HLA-DQ) and immune markers in a large population of type 1 diabetic (T1D) children and adolescents residing in the same environment, but of different ethnic origin: European Caucasians (EC), Moghrabi
Autor:
Karin Lange, Henrik B. Mortensen, Andreas Neu, Fergus J. Cameron, Timothy Barrett, J.-J. Robert, Kenneth Robertson, Przemysława Jarosz-Chobot, Hilary Hoey, C De Beaufort, Harry Dorchy
Publikováno v:
Pediatric Diabetes. 16:402-406
Modern insulin regimens for the treatment of type 1 diabetes are highly individualized. The concept of an individually tailored medicine accounts for a broad variety of different insulin regimens applied. Despite clear recommendations for insulin man